Microbes attached to surfaces and form biofilms where they are difficult to eradicate. Here they are embedded in a complex matrix of polymers and are much less sensitive against antibiotics or the immune system. This is a growing problem, especially for implants; hence, novel approaches are urgently needed to control biofilm infections. Many of these approaches interfere with the communication between the microbial cells required for biofilm formation and maintenance, a process known as quorum sensing. But microbes have also several mechanisms to disperse their own biofilms if conditions become unfavourable. Recently, it has been found that the pathogen Pseudomonas aeruginosa disperses its mature biofilms using cis-2-decenoic acid. This fatty acid belongs to a group of cis-2-alkenoic acids which are known from several bacteria and are also triggering the communication between different species. In this review the biosynthesis of these compounds, their signal transduction and their role in species-species communication are presented. Examples are discussed where cis-2-alkenoic acids have been used to eradicate biofilms and enhance the sensitivity of pathogens against antibiotics, either alone or in combination with antibiotics. Although this presents an interesting approach for the control of biofilm infections it is still in its infancy and a much broader characterization of the effects of cis-2-alkenoic acids are needed before moving to any medical application.
the human pathogens S. aureus and S. epidermidis cyclic peptides have this role.
Since most bacteria live in microbial communities the quorum-sensing signals not only serve for quorum-sensing by cells of the same species but also influences foreign species [29] as has been shown for example for Escherichia coli [30] . While the pathogen Burkholderia cepacia reacts to AHLs produced by another pathogen, Pseudomonas aeruginosa, the reverse is not the case [31] . This probably explains why B.
cepacia always occurs together with P. aeruginosa in the cystic fibrosis lungs while P. aeruginosa is often found without B. cepacia [32] . Another autoinducer signal interaction has been described between the oropharyngeal flora and P. aeruginosa in cystic fibrosis. The autoinducer AI-2 4 is produced only by the oropharyngeal flora, whereas P. aeruginosa reacts to AI-2 without producing it [33] .
These examples show only the tip of the iceberg in the highly diverse kingdom bacteria. AHLs, AIP and most other autoinducers are species-specific and often several autoinducers are produced by the same cell enabling the fine-tuning of signalling [34] . Furthermore, we still know only for a small number of bacteria species their quorum-sensing autoinducers and even for those a number of other autoinducers have been described. Among them are diketopiperazines 6 -9 formed by two condensed amino acids [35] , 2-alkyl-4-quinolones, e.g. the Pseudomonas aeruginosa quinolone signal (PQS) 10, in Pseudomonas aeruginosa [36] , farnesol 11 in several fungi [37] or the unique bradyoxetin 12 [38] (Figure 1) . However, for diketopiperazines their role remains unclear as there are some contradicting reports on their effects [39] .
The obvious way for the control of biofilm infections is blockage of the quorum-sensing signalling cascade and many studies were directed towards this goal. Bacteria, however, cannot only form biofilms, they 3 also have to have mechanisms to disperse their biofilms and to convert the cells back to planktonic cells. This is important if unfavourable conditions occur and living in a biofilm is becoming a disadvantage. Still, very little is known about the routes taken by different pathogens to disperse their biofilms. One principle was discovered when Pseudomonas aeruginosa biofilms were treated with cell-free medium from old cultures and responded by the self-destruction of the biofilm. The responsible compound triggering this event was found to be cis-2-decenoic acid 13 [40] . Homologues were known for many years as diffusible signalling factor (DSF) in several bacteria. host this review will focus on these diffusible signalling factors and discuss their occurrence, regulation, biosynthesis and potential applications in medicine.
Interspecies communications seems to be the prime target of DSFs
When the plant pathogen Xanthomonas campestris was studied for factors regulating extracellular degradative enzymes and extracellular polysaccharide (EPS) virulence factors it was found that mutants lacking these factors could be restored by components extracted from the supernatant [42] . These components were termed diffusible signaling factors. Chemical analysis identified 11-methyl-cis-2-dodecenoic acid 16 as the responsible compound. Later on similar compounds, 13 -23, were found also in Xylella fastidiosa, Stenotrophomonas maltophila, Pseudomonas aeruginosa, several Burkholderia species, including the only known double unsaturated DSF 23, [43] and some other bacteria (Figure 2) suggesting a more widespread occurrence of this type of signaling [44] . The cis-unsaturated double bond at the 2-position is a key structural feature for activity and its hydrogenation leads to products of lower activities of 1-2 orders. Hence, it can be seen as the signature for DSFs.
For Xanthomonas species it was also shown that the methyl branch increases the activity 60-to 120-fold compared to the unbranched cis-2-dodecenoic acid and cis-2-tridecenoic acid. Therefore, chain length and methyl-branching modulate the activity of the different DSFs but they do it in a species-specific way.
Synthesis and perception of DSF in Xanthomonas campestris require products of the rpf gene cluster (for regulation of pathogenicity factors). Similar gene clusters have also been found in many but not all DSFs producing bacteria [45] . Only recently the biosyntheses of the DSFs has been elucidated [46] . For Pseudomonas aeruginosa the involvement of the putative enoyl-coenzyme A hydratase DspI showing significant homologies to the protein RpfF of Xanthomonas campestris has been identified [47] . cis-2-Dodecenoic acid of Burkholderia cenocepacia is synthesized from the acyl carrier protein (ACP) thioester of 3-hydroxydodecanoic acid which is then converted by the enzyme RpfF first to cis-2-dodecenoyl-ACP. But RpfF catalyzes not only dehydration of 3-hydroxydodecanoyl-ACP to cis-2-dodecenoyl-ACP, it also cleaves the thioester to release the free acid [48] . However, the mechanisms by which DSFs are degraded are still unknown.
Most genes of the rpf gene cluster, however, are involved in signal perception and transduction. This is achieved by sensor kinases anchored in the cytoplasmic membrane [49] . Here again the sensor kinase RpfC of Xanthomonas campestris is the best understood system. It consists of a membrane spanning sensory domain, a histidine kinase domain, an ATP kinase binding domain, followed by a receiver domain and a histidine phosphotransfer domain. The structure of the corresponding Burkholderia cenocepacia sensor kinase RpfR is similar but in B. cenocepacia there are only two transmembrane helices instead of the 5 helices in Xanthomonas campestris. In addition, B. cenocepacia harbours a second sensor kinase, BCM0227, and Xanthomonas campestris pv. campestris also has a second one, RpfS, controlling the expression of a subset of genes [50] . The sensor kinase in Pseudomonas aeruginosa has also 5 transmembrane helices but the histidin phosphotransfer domain is missing. After binding of DSF the histidine kinase domain is autophosphorylated requiring ATP. The phosphorelay signalling then leads to the transfer of the phosphate to the receiver domain and then to the histidine phosphotransfer domain. From here the cyclic di-GMP phosphodiesterase RpfG is phosphorylated causing changes in the level of cyclic di-GMP in the cell which in turn affects, e.g. the synthesis of virulence factors or causes biofilm dispersal [51] . The sensor kinase RpfC of Burkholderia cenopacia controls only a subset of DSF-regulated genes and another regulation mechanism was identified. Upon binding of the DSF of Burkholderia RpfR becomes a potent c-di-GMP phosphodiesterase leading to the control of several DSFinfluenced genes [52] . The analysis of 82 Stenotrophomonas maltophilia clinical isolates revealed the presence of two distinct classes of rpfC-rpfF genes. While only one class was able to form DSF the other one seemed to repress permanently DSF-formation [53] . Obviously, at least S. maltophilia can infect humans even without the DSF-regulation system.
DSFs have a multitude of effects within the cell and they interfere with other quorum-sensing systems of the cell [54, 55] . In Burkholderia cenocepacia, cis-2-dodecenoic acid 14 increases motility and biofilm formation, but also virulence [56] . In Stenotrophomonas maltophilia 11-methyl-cis-2-dodecenoic acid 16 and in Burkholderia cenocepacia cis-2-dodecenoic acid 14 stimulate the secretion of outer membrane vesicles. These small vesicles contain large amount of outer membrane proteins which are involved in virulence and biofilm formation. They usually also contain metallo-β-lactamase and serin-β-lactamase, responsible for the resistance against certain antibiotics but when induced by the DSF the β-lactamases are absent [57] . Interestingly, the AHLquorum sensing system and that of DSF seem to interact [58] .
Comparative transcriptome analysis in
Pseudomonas aeruginosa demonstrated a large number of genes being differently regulated by cis-2-decenoic acid 13 [59] , however, a clear pattern explaining the altered phenotype could not be deduced from these experiments.
As in Xanthomonas campestris these DSFs mediate the interaction between the producing bacteria and other organisms but are also involved in biofilm formation, production of virulence factors or stress tolerance [60] . From the opportunistic pathogen Stenotrophomonas maltophila several fatty acids (14 -21) have been identified which facilitate movement of its cells [61] and mediate the communication between
Stenotrophomonas maltophila and the pathogen Pseudomonas aeruginosa. The DSFs produced by S. maltophila cause in P. aeruginosa increased stress tolerance including higher resistance against cationic antimicrobial peptides [62] . Interestingly, 12-methyl-tetradecanoic acid 22 not found in Stenotrophomonas maltophila blocked swarming motility completely at 10 µg mL -1 in Pseudomonas aeruginosa and led to reduced biofilm formation by 31 % [63] . Another DSF, cis-2-dodecenoic acid 14, enabled bacteria-fungus interaction, e.g. between
Burkholderia cenocepacia and Candida albicans [64] . The same fatty acid, cis-2-dodecenoic acid, downregulates in Pseudomonas aeruginosa biofilm formation and inhibits its type-III secretion system [65] . Members of the Gammaproteobacteria are also affected by this DSF as has been shown for the genus Francisella.
Francisella tularensis is a highly infectious pathogen causing tularaemia in humans. The closely related
Francisella novicida, often used a model organism to study this pathogen, reacts to cis-2-dodecenoic acid by the dispersion of its biofilm. This effect is also influenced by chitinase as experiments with chitinase inhibitors could show. In addition to biofilm dispersal the DSF also led to increased siderophore production [66] . 11-Methyl-cis-2-dodecenoic acid 16 of Stenotrophomonas maltophilia blocks the yeast to hyphal transition of Candida albicans and kills the fungal cells [67] . All these examples show the broad diversity of species-species interactions mediated by DSFs.
Prevention and dispersal of biofilms using cis-2-alkenoic acids or their derivatives
The identification of cis-2-decenoic acid as the active compound dispersing preexisting biofilms of Pseudomonas aeruginosa opened novel possibilities to eradicate biofilms and initiated a number of studies for the elucidation of the mechanism and effects [68] . Marques et al. studied the effect of the compound on the metabolic status of Pseudomonas aeruginosa and Escherichia coli and found that it could convert persister cells from a dormant to a metabolically active state, making them more sensitive to antibiotic treatments. cis-2-Decenoic acid increased the respiratory activity caused by changes in protein abundances. As a consequence these cells became more sensitive against antibiotics and the number of surviving cells decreases in biofilm treated with such a combined therapy [69] . When methicillin-resistant Staphylococcus aureus (MRSA) were exposed to 125 μg mL -1 cis-2-decenoic acid the formation of biofilms and at >500 μg mL -1 growth was inhibited.
This characteristic was used in a drug release experiment where a chitosan sponge was loaded with cis-2-decenoic acid and the concentration of this DSF was high enough over 5 days to prevent biofilm formation [70] .
cis-2-Alkenoic acids do not only interfere with the biofilm formation of bacteria but also of fungi. Cis-2-dodecenoic acid 14 at 90 μM reduced the ability of C. albicans to adhere to plates and catheters by 4 and 25 fold, respectively, disrupting the formation of a biofilm. This DSF reduced the level (4 and 0.25 fold) of expression from some adhesion genes (ALS1 and EAP1) and increased the level of YWP1 (4 fold), a protein that had an antiadhesive activity [71] . Furthermore, 14 showed only activity in the initial adhesion process, because when the yeast had germinated and formed the normal hyphae, these were unaffected by subsequent addition of 14 [72] .
cis-2-Alkenoic acids are relatively simple molecules which facilitates the generation of analogues.
However, only few analogues of cis-2-alkenoic acids have yet been tested for their effect on biofilms of pathogens. 4,5-disubstituted-2-aminoimidazole-triazole conjugates, e.g. 36, inhibited biofilm formation of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii and resensitized them against antibiotics. When the activity of these compounds were compared with the one of cis-2-decenoic acid they were found to be more active [73] . However, since no attempt was made to elucidate the mechanism of action it can only be speculated that they act similar to cis-2-decenoic acid. Gutierrez et al. found that some 2-bromoalkanoic acids reduced the capability of Pseudomonas aeruginosa to form biofilms. Treatment of Pseudomonas aeruginosa PAO1 with 5 mM 2-bromohexanoic acid 37, 2-bromooctanoic acid 38 and 2-bromodecanoic acid 39 resulted in a reduction of biofilm formation by 29%, 40% and 69%, respectively, over 48 h (Figure 3) . Although the exact mode of action of these compounds on the biofilm was not investigated it could be shown that this effect was independent of the inhibition of the formation of rhamnolipids. The same compounds with 2 mM concentration caused after 120 h a reduction of rhamnolipid formation by 89%, 71% and 29%, respectively, showing just the reversed order of activity of the bromoalkanoic acids compared to biofilm inhibition and pointing to a mechanism independent from biofilm formation [74] . Because the main effect of cis-2-decenoic acid 13 on various biofilms is their dispersion the idea is obvious that a combination with disinfectants or antibiotics could be a promising approach to control biofilm infections. The success of such an approach has been demonstrated for Staphylococcus aureus, Bacillus cereus, Salmonella enterica and Escherichia coli. When pre-established biofilms of these four bacteria were treated with 310 nM cis-2-decenoic acid 14 and disinfectants or antibiotics an 80 % reduction of the biofilm mass was observed [75] . This works not only with pure cultures but also with mixed communities and biofilms of Escherichia coli growing together with Klebsiella pneumonia could be reduced by 78 % when treated with 310 nM cis-2-decenoic acid and ciprofloxacin or ampicillin. Moreover, most of the cells remaining in the biofilm were also killed [76] . The same treatment where the antibiotic has been replaced by a disinfectant could also reduce significantly biofilms of Streptococcus mutans, a pathogen of dental plaques [77] . cis-2-Decenoic acid 13 seems to be much more active than the homologous cis-2-dodecenoic acid 14. When using 50 μM cis-2-dodecenoic acid 14 instead of cis-2-decenoic acid 13 and gentamycin a similar, although much weaker, effect could be seen for Bacillus thuringiensis, Staphylococcus aureus, Neisseria subflava and Pseudomonas aeruginosa. In the same study the effects of homologues of trans-and cis-2-alkenoic acids in combination with three different antibiotics on Bacillus cereus have been determined. It was found that in general longer fatty acids were more active than shorter ones but the configuration of the double bond and the added antibiotics were even more important for the activity. While, e.g. trans-2-tetradecenoic acid 29 was the most active trans-fatty acid in this study in combination with gentamycin, the most active cis-fatty acid was cis-2-pentadecenoic acid 34. cis-2-Tetradecenoic acid 15 was less active than the homologous cis-2-penetadecenoic acid 34 when applied together with getamycin but equally active when combined with kanamycin ( Figure 4 ) [78] . At least for
Bacillus cereus there seems to be not a single optimal cis-2-alkenoic acid and it is reasonable to assume that for other bacteria an even different pattern of activity will be found. [78] .
Discussion and outlook
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The discovery of cis-2-decenoic acid 13 from Xanthomonas species and its role in bacteria-plant communication had no relevant impact on medicinal chemistry. This changed dramatically when the same compound from Pseudomonas aeruginosa was found to disperse various biofilms. Immediately, several applications could be imagined and the dissection of it biosynthesis, regulation and mode of action started. Now we know that cis-2-decenoic acid belongs to a group of bioactive cis-2-alkenoic acids produced by several pathogens often also for the purpose of inter-species interactions. This characteristic made cis-2-alkenoic acids interesting candidates for the modulation of pathogenic biofilm communities. Because several cis-2-alkenoic acids can disperse established biofilms and increase their sensitivity towards antibiotics approaches combining them with antibiotics or disinfectants have been investigated. The first results were rather promising, although these studies are only the beginning. We still do not fully understand the effects of cis-2-alkenoic acids on the bacterial cells, their entire circuits of regulation, their structure activity relationships, or their mode of action on biofilms, to name only a few open questions. We also still do not know their pharmacokinetics and their effects on complex microbial communities in biofilms or in animal infection models. This all will be studied in the coming years but the expectations are high that cis-2-alkenoic acids will develop into an important tool for the control of biofilm infections.
Many characteristics of cis-2-alkenoic acids are still not clear, e.g. Davies et al. [40] reported dispersion of S. aureus biofilms with 10 nM of cis-2-decenoic acid 13 but Su et al. [73] needed about 200 µM to achieve this effect. For the characterization of effects of cis-2-alkenoic acids we need strictly controlled protocols which will allow the comparison of results between different compounds, different pathogens and different laboratories.
These data are essential for the establishment of QSAR required for the search for compounds with highly specific activities. After finding such compounds their efficiencies in host-pathogen models have to be demonstrated. For the application in drug release systems on implants it is essential to know that they are active but also that they do not hinder the integration of the implant. At least for cis-2-decenoic acid no effect on osteoblast differentiation has been detected [79] . If in animal experiments these positive results can be confirmed several combinations of antibiotics with cis-2-alkenoic acids can be the answer to specific biofilm infections of the host. Applications of cis-2-alkenoic acids are still in its infancy but the results obtained so far are very promising for the development of drugs against biofilm infections.
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